Cadence Bank Gilead Sciences, Inc. Transaction History

Cadence Bank

$1.45 Billion
Q3 2024

A detailed history of Cadence Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cadence Bank holds 122,969 shares of GILD stock, worth $11.6 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

122,969

Previous 119,169 3.19%

Holding current value

$11.6 Million

Previous $8.18 Million 26.06%

% of portfolio

0.71%

Previous 0.61%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $253,042 - $319,162	3,800 Added 3.19%	122,969 $10.3 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $115,311 - $133,078	1,826 Added 1.56%	119,169 $8.18 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $13,814 - $16,846	-193 Reduced 0.16%	117,343 $8.6 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $39,712 - $45,034	542 Added 0.46%	117,536 $9.52 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $1,183 - $1,290	-16 Reduced 0.01%	116,994 $8.77 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $306,624 - $349,747	4,034 Added 3.57%	117,010 $9.02 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $85,350 - $97,240	-1,104 Reduced 0.97%	112,976 $9.37 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $21,687 - $31,135	348 Added 0.31%	114,080 $9.79 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $211,367 - $241,435	3,550 Added 3.22%	113,732 $7.02 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $208,196 - $234,491	3,607 Added 3.38%	110,182 $6.81 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $6.17 Million - $7.74 Million	106,575 New	106,575 $6.34 Million
Q2 2020 Jul 27, 2020	SELL	$72.34 - $84.0 $238,939 - $277,452	-3,303 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $3.23 Million - $4.14 Million	-51,644 Reduced 93.99%	3,303 $247,000
Q4 2019 Feb 04, 2020	BUY	$61.62 - $67.78 $3.39 Million - $3.72 Million	54,947 New	54,947 $3.57 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $3.35 Million - $4.09 Million	-46,033 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $3.28 Million - $3.84 Million	46,033	46,033 $0

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.

Account